Aveanna Healthcare Holdings Set to Release Q4 Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy AVAH?
Source: seekingalpha
- Earnings Announcement: Aveanna Healthcare Holdings (AVAH) is set to announce its Q4 earnings on March 19 before market open, with consensus EPS estimate at $0.16, reflecting a substantial 220% year-over-year increase, and revenue expected at $649.48 million, up 24.9% year-over-year.
- Consistent Outperformance: Over the past year, Aveanna has consistently beaten EPS and revenue estimates, demonstrating strong profitability and market adaptability, which enhances investor confidence in the stock.
- Revisions Trend: In the last three months, EPS estimates have seen seven upward revisions with no downward adjustments, while revenue estimates experienced six upward revisions and one downward, indicating analysts' optimistic outlook on the company's future performance.
- Acquisition Strategy: Aveanna plans to acquire Family First Homecare for $176 million, a move that will not only expand its market share but also strengthen its competitive position in the home healthcare sector, further driving company growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVAH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVAH
Wall Street analysts forecast AVAH stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 7.070
Low
10.00
Averages
10.75
High
11.00
Current: 7.070
Low
10.00
Averages
10.75
High
11.00
About AVAH
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement: Aveanna Healthcare Holdings (AVAH) is set to announce its Q4 earnings on March 19 before market open, with consensus EPS estimate at $0.16, reflecting a substantial 220% year-over-year increase, and revenue expected at $649.48 million, up 24.9% year-over-year.
- Consistent Outperformance: Over the past year, Aveanna has consistently beaten EPS and revenue estimates, demonstrating strong profitability and market adaptability, which enhances investor confidence in the stock.
- Revisions Trend: In the last three months, EPS estimates have seen seven upward revisions with no downward adjustments, while revenue estimates experienced six upward revisions and one downward, indicating analysts' optimistic outlook on the company's future performance.
- Acquisition Strategy: Aveanna plans to acquire Family First Homecare for $176 million, a move that will not only expand its market share but also strengthen its competitive position in the home healthcare sector, further driving company growth.
See More
- Acquisition Agreement: Aveanna Healthcare announced an agreement to acquire Family First Homecare for $175.5 million, aiming to expand its geographic footprint in specialized care, with the transaction expected to close in Q2 2026.
- Diverse Funding Sources: The acquisition will be funded through a combination of cash on hand and debt, demonstrating the company's flexibility in capital management and confidence in future growth.
- Clear Market Positioning: Family First Homecare operates 27 locations across seven states, including Florida, focusing on private duty nursing services for the pediatric population, aligning with Aveanna's strategic mission to deliver high-quality care.
- High Cultural Fit: Aveanna CEO Jeff Shaner emphasized that Family First Homecare is a tremendous cultural fit, which is expected to bring unprecedented value and clinical innovation to payors and stakeholders.
See More
- Earnings Release Schedule: Aveanna Healthcare is set to announce its fourth quarter and full year results on March 19, 2026, before market open, which is expected to provide investors with critical financial performance data to assess the company's operational status.
- Conference Call Details: The company will host a conference call at 10:00 a.m. (Eastern Time) on the same day, allowing investors to participate by dialing 1-877-407-0789, with international callers using 1-201-689-8562, ensuring global investor engagement in the discussion.
- Replay Service: A replay of the conference call will be available three hours after its conclusion, accessible by dialing 1-844-512-2921 (international callers can use 1-412-317-6671), with the replay service lasting until March 26, 2026, facilitating information access for those unable to attend live.
- Online Webcast: Investors can also listen to a simultaneous webcast of the conference call via the Investor Relations section of the company's website, with the online replay available for one week post-call, further enhancing information accessibility and transparency.
See More
- Healthcare Stocks Rise: Late Wednesday afternoon, healthcare stocks broadly increased, reflecting growing market confidence in the healthcare sector, which may attract more investor attention to this field.
- NYSE Health Care Index Performance: The rise in the NYSE Health Care Index indicates a healthy overall condition for the industry, potentially driving up stock prices of related companies and enhancing investor returns.
- Market Trends: The positive performance of the healthcare sector may be linked to recent policy changes and increasing market demand, demonstrating sustained investor interest in healthcare services and products.
- Investor Confidence: The rise in healthcare stocks could bolster investor confidence in the broader market, especially amid increasing economic uncertainty, as the healthcare sector is viewed as a relatively safe investment choice.
See More

- Revenue Guidance Increase: Aveanna Healthcare raised its 2025 revenue guidance to $2.425B-$2.445B, surpassing the previous estimate of $2.375B from November, indicating strong growth potential in the home healthcare sector.
- EBITDA Guidance Boost: The company increased its adjusted EBITDA forecast to nearly $318M-$322M, up from over $300M previously, reflecting improved operational efficiency and enhanced profitability.
- 2026 Outlook: Aveanna expects to generate $2.54B-$2.56B in revenue for 2026, slightly below the consensus of $2.57B, yet still indicating a sustained growth trajectory and competitive strength in the market.
- Investor Conference Preview: The financial guidance update coincides with the company's presentation at the J.P. Morgan Healthcare Conference in San Francisco, which is expected to attract investor interest and bolster market confidence.
See More
- 2025 Revenue Forecast: Aveanna Healthcare anticipates revenue for 2025 to reach approximately $2.445 billion, an increase from previous estimates, indicating sustained growth potential in the high-cost patient care sector.
- Net Income Outlook: The expected net income for 2025 is projected to be between $181 million and $220 million, reflecting the company's profitability and financial stability in the complex healthcare market.
- Initial 2026 Guidance: The company forecasts revenue for 2026 to be between $2.54 billion and $2.56 billion, demonstrating confidence in future growth despite not providing net income guidance due to market volatility.
- Adjusted EBITDA Expectations: The adjusted EBITDA for 2025 is expected to range from $318 million to $322 million, indicating ongoing efforts to enhance operational efficiency and cost control will continue to drive financial performance.
See More









